P3MO Ltd (“the Company” or “P3MO”) is an enterprise SaaS platform that simplifies complex modernisation and transformation projects – from multi-million-pound drug approval programmes in pharma to large-scale IT upgrades in government.

• Transformation programmes in the public and private sectors fail at alarming rates - over 88% miss their objectives, wasting significant time and money.

• Founded by experienced transformation project managers and tech developers, P3MO solves the challenges of enterprise transformation with a software platform designed for both managers and specialist delivery teams.

• Multi-national customers include AstraZeneca, where 70+ global projects saw a 72% cut in governance time, a 90% reduction in reporting effort and a $1.2m saving through identification of a critical regulatory milestone.

• Strong traction with £1.3m cumulative revenue to date, £280,000 Annual Recurring Revenue (‘ARR’) and a £2.2m near-term pipeline.

• Other customers include Great Places Housing Group and a US and Colombia based petrochemical engineering firm.

• £1.25m (£4.1m Growthdeck pre-fundraise valuation).
• £250k already invested by Fuel Ventures with a further £500k sought from co-investors.
• £500,000 opportunity for Growthdeck Investors (9.57% stake).
• Exit targeted from 2030 at £100m valuation (4x ARR).
• EIS-qualifying.
• Funding will be used to scale rollouts with enterprise customers and enhance product features including AI analytics.